» Articles » PMID: 30113467

Bacteriuria and Asymptomatic Infection in Chronic Patients with Indwelling Urinary Catheter: The Incidence of ESBL Bacteria

Overview
Specialty General Medicine
Date 2018 Aug 17
PMID 30113467
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Urinary tract infections due to the presence of a urinary catheter represent a real problem for patients who have to carry such an invasive device for a long time.Our aim was to identify the susceptibility of extended spectrum beta lactamases (ESBL) versus non-ESBL bacteria to antibiotics in urinary tract infections in patients who are chronic carriers of urinary catheters.The retrospective study included a period of 5 years, a total of 405 patients who are chronic carriers of urinary catheters, admitted to rehabilitation and palliative care units.Escherichia coli (E coli) was isolated in 41.2% of patients, Klebsiella pneumoniae (K pneumoniae) in 24.7%, and Proteus mirabilis (P mirabilis) in 15.3%. E coli microbial resistance rates ranged from a minimum of 7.5% (nitrofurantoin) to a maximum of 77.1% (ampicillin). In the case of K pneumoniae, microbial resistance ranged from 34.2% (netilmicin) to 73.2% (ceftriaxone). Resistance rates of P mirabilis ranged from 11.1% (cefepim) to 89.5% (ampicillin). Positivity of ESBL bacteria was identified in 47.4% of patients. Resistance rates of ESBL-positive E coli ranged from 50.0% (ceftriaxone) to 88.1% (cefepime), and ESBL-negative E coli rates ranged from 3.4% (cefepime) to 64.4% (amikacin). Resistance rates of ESBL-positive K pneumoniae ranged between 39.1% (netilmicin) and 85.1% (ceftriaxone), and ESBL-negative K pneumoniae between 7.1% (cefepime) and 53.3% (amikacin). In cases of ESBL-positive P mirabilis, rates ranged from 13.3% (cefepime) to 90.3% (ceftriaxone), whereas in cases of ESBL-negative P mirabilis, rates ranged between 8.3% (cefepime) and 80.0% (trimetroprim).Bacteriuria and asymptomatic catheter infection in chronic carriers is an important public health concern due to the frequent presence of multidrug-resistant bacteria. Our study highlights the need to develop control programs of catheter infections to minimize the risk of infections associated with these medical devices, and also the need for treatment of the infection rather than catheter colonization or contamination.

Citing Articles

Investigation of the susceptibility of clinical infection loads to nitric oxide antibacterial treatment.

Estes Bright L, Mondal A, Pinon V, Kumar A, Thompson S, Brisbois E Nitric Oxide. 2024; 154():19-28.

PMID: 39561942 PMC: 11729576. DOI: 10.1016/j.niox.2024.11.003.


Antimicrobial resistance and ESBL production in uropathogenic : a systematic review and meta-analysis in Ethiopia.

Asmare Z, Erkihun M, Abebe W, Tamrat E JAC Antimicrob Resist. 2024; 6(3):dlae068.

PMID: 38716402 PMC: 11073753. DOI: 10.1093/jacamr/dlae068.


Incidence of catheter-associated urinary tract infections by Gram-negative bacilli and their ESBL and carbapenemase production in specialized hospitals of Bahir Dar, northwest Ethiopia.

Asmare Z, Awoke T, Genet C, Admas A, Melese A, Mulu W Antimicrob Resist Infect Control. 2024; 13(1):10.

PMID: 38273339 PMC: 10809431. DOI: 10.1186/s13756-024-01368-7.


Total Knee Arthroplasty in Patients with Spinal Cord Injury: Impact on Medical Complications, Hospital Costs and Length of Stay.

Sambandam S, Cheppalli N, Menedal A, Senthil T, Sakthivelnathan V, Mounasamy V J Am Acad Orthop Surg Glob Res Rev. 2023; 7(4).

PMID: 37026775 PMC: 10082245. DOI: 10.5435/JAAOSGlobal-D-22-00145.


Is early time to positivity of blood culture associated with clinical prognosis in patients with bloodstream infection?.

Hou W, Han T, Qu G, Sun Y, Yang D, Lin Y Epidemiol Infect. 2023; 151:e43.

PMID: 36805070 PMC: 10028975. DOI: 10.1017/S0950268823000262.


References
1.
Tambyah P, Maki D . Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000; 160(5):678-82. DOI: 10.1001/archinte.160.5.678. View

2.
Hooton T, Bradley S, Cardenas D, Colgan R, Geerlings S, Rice J . Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50(5):625-63. DOI: 10.1086/650482. View

3.
Stickler D . Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol. 2008; 5(11):598-608. DOI: 10.1038/ncpuro1231. View

4.
WARREN J, Tenney J, Hoopes J, Muncie H, ANTHONY W . A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982; 146(6):719-23. DOI: 10.1093/infdis/146.6.719. View

5.
Gopal Rao G, Batura D, Batura N, Nielsen P . Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London. Infect Dis (Lond). 2015; 47(10):719-24. DOI: 10.3109/23744235.2015.1055588. View